These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 9863624)

  • 21. The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s).
    Nabhan C; Xiong Y; Xie LY; Abou-Samra AB
    Biochem Biophys Res Commun; 1995 Jul; 212(3):1015-21. PubMed ID: 7626087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor.
    Dautzenberg FM; Dietrich K; Palchaudhuri MR; Spiess J
    J Neurochem; 1997 Oct; 69(4):1640-9. PubMed ID: 9326293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I.
    Yu J; Xie LY; Abou-Samra AB
    Endocrinology; 1996 Jan; 137(1):192-7. PubMed ID: 8536612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
    McCarthy JR; Heinrichs SC; Grigoriadis DE
    Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM; Wille S
    Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri.
    Palchaudhuri MR; Hauger RL; Wille S; Fuchs E; Dautzenberg FM
    J Neuroendocrinol; 1999 Jun; 11(6):419-28. PubMed ID: 10336722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.
    Tezval H; Jahn O; Todorovic C; Sasse A; Eckart K; Spiess J
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9468-73. PubMed ID: 15192151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
    Primus RJ; Yevich E; Baltazar C; Gallager DW
    Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional corticotropin-releasing factor receptors in human neuroblastoma cells.
    Dieterich KD; DeSouza EB
    Brain Res; 1996 Sep; 733(1):113-8. PubMed ID: 8891255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticotropin-releasing factor (CRF) agonists stimulate testosterone production in mouse leydig cells through CRF receptor-1.
    Heinrich N; Meyer MR; Furkert J; Sasse A; Beyermann M; Bönigk W; Berger H
    Endocrinology; 1998 Feb; 139(2):651-8. PubMed ID: 9449637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a selective photoactivatable antagonist for corticotropin-releasing factor receptor, type 2 (CRF2).
    Bonk I; Rühmann A
    Eur J Biochem; 2002 Nov; 269(21):5288-94. PubMed ID: 12392562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.
    Dautzenberg FM; Kilpatrick GJ; Wille S; Hauger RL
    J Neurochem; 1999 Aug; 73(2):821-9. PubMed ID: 10428081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross-linking studies.
    Grigoriadis DE; De Souza EB
    J Biol Chem; 1988 Aug; 263(22):10927-31. PubMed ID: 2839512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression cloning of a human corticotropin-releasing-factor receptor.
    Chen R; Lewis KA; Perrin MH; Vale WW
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8967-71. PubMed ID: 7692441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands.
    Hoare SR; Sullivan SK; Pahuja A; Ling N; Crowe PD; Grigoriadis DE
    Peptides; 2003 Dec; 24(12):1881-97. PubMed ID: 15127940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling.
    Rühmann A; Köpke AK; Dautzenberg FM; Spiess J
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10609-13. PubMed ID: 8855226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated.
    Perry SJ; Junger S; Kohout TA; Hoare SR; Struthers RS; Grigoriadis DE; Maki RA
    J Biol Chem; 2005 Mar; 280(12):11560-8. PubMed ID: 15653688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediation of corticotropin releasing factor type 1 receptor phosphorylation and desensitization by protein kinase C: a possible role in stress adaptation.
    Hauger RL; Olivares-Reyes JA; Braun S; Catt KJ; Dautzenberg FM
    J Pharmacol Exp Ther; 2003 Aug; 306(2):794-803. PubMed ID: 12734388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.